Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning
Row Comes Ahead Of Expected CHMP Decision
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
You may also be interested in...
Helped by government support for the development of COVID-19 drugs and vaccines, Celltrion’s monoclonal antibody becomes the first therapeutic for the disease to be officially approved in South Korea.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.